Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (unaudited)

v3.19.3
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (17,149) $ (16,690)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 157 106
(Gain) loss on change in estimated fair value of contingent royalty obligation (68) 244
Share based compensation 2,530 1,735
Unrealized gain on investments (5)
Amortization of bond premium 15
Inventory write-down 76 574
Fixed asset impairment 35
Non-cash operating lease expense 185
Warrant expense 3,156
Changes in operating assets and liabilities:    
Accounts receivable 5 (18)
Inventory (732) (614)
Prepaid expenses and other current assets (43) (74)
Accounts payable and accrued expenses 593 1,141
Operating lease liabilities - current and non-current (182)
Other current and non-current liabilities 203 (108)
Net cash used in operating activities (14,395) (10,533)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of fixed assets (361) (194)
Proceeds from long-term deposits 11
Repayment of shareholder loan receivable 126
Purchase of held-to-maturity securities (4,863)
Purchase of available-for-sale securities (9,609) (5,026)
Proceeds from sale of available-for-sale securities 2,000 2,000
Proceeds from maturity of held-to-maturity securities 3,130
Net cash used in investing activities (7,970) (4,816)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Gross proceeds from public offering 20,000 17,500
Proceeds from exercise of over-allotment options 1,945
Proceeds from exercise of options 2 306
Financing fees (1,915) (2,509)
Net cash provided by financing activities 20,032 15,297
NET DECREASE IN CASH AND CASH EQUIVALENTS (2,333) (52)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 18,050 6,939
CASH AND CASH EQUIVALENTS AT END OF PERIOD 15,717 6,887
CASH PAID FOR:    
Interest
Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:    
Reclassification of deferred financing costs from current assets to additional paid-in capital 602
Cashless exercise of options 2
Deferred financing fees included in accounts payable and accrued expenses $ 59